LOMBARDI, CARLO MARIO
 Distribuzione geografica
Continente #
NA - Nord America 15.946
AS - Asia 8.252
EU - Europa 6.873
SA - Sud America 1.572
Continente sconosciuto - Info sul continente non disponibili 399
AF - Africa 195
OC - Oceania 25
Totale 33.262
Nazione #
US - Stati Uniti d'America 15.563
SG - Singapore 2.748
CN - Cina 2.726
BR - Brasile 1.292
UA - Ucraina 1.286
IT - Italia 1.167
PL - Polonia 1.095
HK - Hong Kong 918
DE - Germania 887
VN - Vietnam 537
FI - Finlandia 497
FR - Francia 494
GB - Regno Unito 415
IN - India 334
RU - Federazione Russa 313
TR - Turchia 305
BD - Bangladesh 278
IE - Irlanda 261
CA - Canada 190
SE - Svezia 110
AR - Argentina 105
MX - Messico 95
NL - Olanda 73
JP - Giappone 67
ZA - Sudafrica 55
IQ - Iraq 53
ES - Italia 49
SA - Arabia Saudita 46
EC - Ecuador 42
BE - Belgio 41
ID - Indonesia 40
CZ - Repubblica Ceca 37
PK - Pakistan 37
CO - Colombia 33
AT - Austria 29
NG - Nigeria 29
VE - Venezuela 29
MA - Marocco 27
JM - Giamaica 25
CL - Cile 21
AU - Australia 19
EE - Estonia 18
LT - Lituania 18
PH - Filippine 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
PY - Paraguay 16
KE - Kenya 15
EG - Egitto 14
UY - Uruguay 14
AL - Albania 13
CR - Costa Rica 13
HN - Honduras 13
NP - Nepal 13
UZ - Uzbekistan 11
BG - Bulgaria 10
PA - Panama 10
BO - Bolivia 9
LV - Lettonia 9
PE - Perù 9
TH - Thailandia 9
DO - Repubblica Dominicana 8
DZ - Algeria 8
KZ - Kazakistan 8
MY - Malesia 8
OM - Oman 8
HU - Ungheria 7
SN - Senegal 7
AZ - Azerbaigian 6
CH - Svizzera 6
ET - Etiopia 6
EU - Europa 6
IL - Israele 6
IR - Iran 6
MU - Mauritius 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
KR - Corea 5
MD - Moldavia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
RO - Romania 5
HR - Croazia 4
KG - Kirghizistan 4
PR - Porto Rico 4
PS - Palestinian Territory 4
BB - Barbados 3
BY - Bielorussia 3
CY - Cipro 3
GT - Guatemala 3
KH - Cambogia 3
LB - Libano 3
LK - Sri Lanka 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
Totale 32.834
Città #
Ashburn 1.531
Singapore 1.361
Fairfield 1.246
Warsaw 1.082
San Jose 991
Jacksonville 926
Hong Kong 916
Woodbridge 793
Beijing 647
Chandler 628
Houston 615
Seattle 545
The Dalles 523
Cambridge 521
Wilmington 505
Council Bluffs 496
Ann Arbor 481
Princeton 448
New York 421
Los Angeles 324
Helsinki 323
Nanjing 313
Dublin 259
Lauterbourg 259
Istanbul 243
Columbus 203
Dallas 185
Ho Chi Minh City 173
Milan 170
Munich 168
Buffalo 127
São Paulo 125
Moscow 120
Santa Clara 118
Pune 111
Brescia 109
Chicago 106
Hanoi 105
Des Moines 104
San Francisco 103
Redondo Beach 102
Nanchang 100
Changsha 95
Shenyang 92
Shanghai 91
San Diego 88
Dearborn 86
Hebei 78
London 78
Orem 75
Phoenix 75
Tianjin 74
Rome 73
Frankfurt am Main 62
Tokyo 61
Jinan 60
Jiaxing 57
Montreal 56
Brooklyn 53
Chennai 50
Boston 45
Hangzhou 45
Turku 45
Nuremberg 44
Guangzhou 42
Atlanta 41
Toronto 40
Rio de Janeiro 39
Romola 39
Brussels 37
Poplar 36
Stockholm 36
Kunming 35
Dong Ket 34
Kocaeli 34
Lancaster 33
Charlotte 32
Mexico City 32
Denver 31
Brno 30
Naples 30
Verona 30
Abuja 29
Zhengzhou 28
Düsseldorf 27
Johannesburg 27
Ningbo 26
Boardman 25
Manchester 25
Washington 25
Amsterdam 24
Mumbai 24
Brasília 23
Haiphong 23
Da Nang 22
Belo Horizonte 21
Dhaka 21
Haikou 21
Riyadh 20
Taizhou 20
Totale 21.171
Nome #
Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance 350
Can we improve the treatment of congestion in heart failure? 320
Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. 304
Impact of serial troponin release on outcomes in patients with acute heart failure: Analysis from the protect pilot study 304
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. 291
Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. 270
Troponin T levels in patients with acute heart failure : clinical and prognostic significance of their delection and release during hospitalisation 265
Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? 264
May 2020 at a glance: ischaemic heart failure and sex-related differences 245
Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. 218
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: A long-term comparison 213
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 212
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 204
Fattori di rischio ed “epidemiologia inversa” nei pazienti con insufficienza cardiaca. 199
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 199
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 197
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 195
2024 update in heart failure 191
Amino acids and derivatives, a new treatment of chronic heart failure? 190
Clinical Presentation and Outcome in a Contemporary Cohort of Patients with Acute Myocarditis: The Multicenter Lombardy Registry 187
Can we prevent or treat renal dysfunction in acute heart failure? 183
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 183
Neurohormonal activation in acute heart failure: results from VERITAS 179
Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients 179
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study 172
A systematic review of in-hospital worsening heart failure as an endpoint in clinical investigations of therapy for acute heart failure 167
Anemia and heart failure : a cause of progression or only a consequence? 166
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 164
Nutrition and Cardiovascular Disease: Finding the Perfect Recipe for Cardiovascular Health 163
Prognostic Value of Serial Clinical, Laboratory and Ecocardiographic Tests in Ambulatory Patients with Chronic Heart Failure 162
Serelaxin a novel treatment for acute heart failure 162
Prognostic value of the absolute lymphocyte count in patients admitted for acute heart failure 161
Prognostic Evaluation Of The Ascending Aorta's Elastic Properties In Patients With Non-Ischemic Dilated Cardiomyopathy: An Echocardiographic Long-Term Follow-Up Study. 160
Cardiovascular and non cardiovascular comorbidities in patients with chronic heart failure. 159
N-terminal pro-B-type natriuretic peptide-guided therapy in patients hospitalized for acute heart failure 158
The management of acute heart failure. 156
Heart failure and anemia: Effects on prognostic variables 156
Nutritional Deficiency in Patients with Heart Failure. 154
N-3 PUFA increase bioavailability and function of endothelial progenitor cells 153
Significato prognostico indipendente della frequenza cardiaca a riposo alla dimissione come predittore di mortalità in pazienti ricoverati per insufficienza cardiaca acuta. 152
Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment. 152
Nutritional Supplementation with Amino Acids in Ambulatory Patients with Idiophatic Dilatated Cardiomyophaty 151
The Additional Role Of Diabetes Mellitus On Hypertension-Related Aortic Stiffness. 149
Arterial Stiffness And Ventricular-Arterial Coupling In Hfref. 149
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 148
Valore prognostico delle variazioni dell'indice di distribuzione dei volumi eritrocitari (RDW) nello scompenso cardiaco cronico. 147
Apnee notturne e insufficienza cardiaca: un problema in via di soluzione. 147
Updates in heart failure: what last year brought to us 145
The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy 144
Assessment of Congestion in Acute Heart Failure: When Simplicity Does Not Go Along With Accuracy 144
Body Mass Index Paradox In Acute Herat Failure 143
Independent role of resting heart rate at discharge as a predictor of mortality after hospitalisation for acute heart failure. 141
Effects of oral amino Acid supplements on functional capacity in patients with chronic heart failure. 141
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group 141
Treatment of Patients Recently Admitted for Acute Heart Failure Based on NT-proBNP Plasma Levels Measurements. Results of a Prospective, Randomized, Single-centre Trial 140
Prognostic value of serial measurements of blood urea nitrogen in ambulatory patients with chronic heart failure 140
Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation 140
Acute heart failure: More questions than answers 140
Six-year prognosis of diabetic patients with coronary artery disease. 139
Echocardiographic elastic properties of ascending aorta and their relationship with exercise capacity in patients with non-ischemic dilated cardiomyopathy 139
In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department 139
The need for evaluating right ventricular adaptation and ventriculo–arterial coupling 138
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 138
The chronic heart failure evolutions: Different fates and routes 137
Acute heart failure 137
Iron deficiency in heart failure 135
Decongestion, Arterial Stiffness And Ventricular-Arterial Coupling In Ahf. 134
In-hospital worsening heart failure in patients admitted for acute heart failure 133
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms. 132
Red cell distribution width and chronic heart failure: prognostic role beyond echocardiographic parameters. 132
Impact of serial troponin release on outcomes in patients with acute heart failure: analysis from the PROTECT pilot study. 131
Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. 131
Cardiorenal Interactions 131
Clinical characteristics and outcome of acute heart failure patients with mid-range ejection fraction. 131
Role of fluid retention in patients hospitalised for acute heart failure. 130
Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome 130
Chronic kidney disease and worsening renal function in acute heart failure: different phenotypes with similar prognostic impact? 130
Preoperative cardiac risks in noncardiac surgery: The role of coronary angiography 130
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: early in vivo cardiovascular effects 129
Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis 129
Acute heart failure: The heart failure patient's journey-the vulnerable phase: Bibliography of one hundred key papers 128
Novel insight into the dangerous connection between diabetes and heart failure 128
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 127
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 127
Exercise performance is a prognostic indicator in elderly patients with chronic heart failure: Application of metabolic exercise cardiac kidney indexes score 127
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 126
La terapia con inotropi del paziente con insufficienza cardiaca: oltre i farmaci tradizionali 126
Le pressioni di riempimento ventricolari e la risposta ventilatoria allo sforzo identificano i pazienti con insufficienza cardiaca ad alto rischio di eventi nonostante la terapia beta-bloccante. 125
Beta 2 adrenergic receptors polymorphism influence: the effects of carvedinol in the patients with cronic heart failure. 125
Prediction of 1-year outcomes after an acute heart failure hospitalisation: importance of variables measured at the time of discharge. 125
Arrhythmias and cardiomyopathy: when arrhythmias come first 124
Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension 124
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 123
School and family-based interventions for promoting a healthy lifestyle among children and adolescents in Italy: A systematic review 123
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 122
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 121
Amino acid supplementation in patients with heart failure 121
Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes 121
The prognostic value of serial troponin measurements in patients admitted for COVID-19 121
Terapia Beta-bloccante nello scompenso cardiaco : nuove prospettive. 119
Totale 16.127
Categoria #
all - tutte 173.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.391


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.262 0 0 0 119 48 77 42 142 80 197 166 391
2022/20231.749 262 92 27 125 168 468 5 165 274 14 84 65
2023/20242.064 124 32 210 172 123 422 92 77 410 50 47 305
2024/20254.656 46 60 76 534 461 388 511 238 406 370 943 623
2025/202610.306 1.032 1.365 746 1.423 1.026 676 1.537 434 573 856 431 207
2026/20272.108 444 439 930 295 0 0 0 0 0 0 0 0
Totale 33.262